Meanwhile, we found that both PHB KO and PHB inducible-KD resulted in a pronounced reduction of SOX2+ or Olig2+ tumor cells in GBM xenografts (Fig. 2k and Supplementary Fig. 3j, k), suggesting a decrease of GSC pool in PHB-deleted tumors. The gene discussed is SOX2; the disease is glioblastoma.